Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 14-Oct-20 4:15 PM View:  | Bjerkholt Eric Chief Financial Officer | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 23,905 | $34.50 | $824,722.00 | (100%) 23.91K to 0 | |
| 14-Oct-20 4:15 PM View: | Iwicki Mark T Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Behar Gregory Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (43%) 18.03K to 10.19K | |
| 14-Oct-20 4:15 PM View: | Oxtoby Andrew Chief Commercial Officer | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 20,250 | $34.50 | $698,625.00 | (100%) 20.25K to 0 | |
| 14-Oct-20 4:15 PM View: | Sheehy Douglas T. See Remarks | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 36,875 | $34.50 | $1,272,190.00 | (100%) 36.88K to 0 | |
| 14-Oct-20 4:15 PM View: | Dallas Jayson Donald Alexan... President and CEO Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 89,250 | $34.50 | $3,079,120.00 | (100%) 89.25K to 0 | |
| 15-Oct-20 7:18 PM View: | Societe Des Produits Nestle... 10% Owner | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Purchase | 54,117,300 | $34.50 | $1,867,049,984.00 | 208% 25.98M to 80.1M | |
| 14-Oct-20 4:15 PM View: | Haumann Brett K Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 13,313 | $34.50 | $459,298.00 | (100%) 13.31K to 0 | |
| 14-Oct-20 4:15 PM View: | Behar Gregory Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition (other) | 10,192 | -- | -- | (100%) 10.19K to 0 | |
| 14-Oct-20 4:15 PM View: | McDade Mark Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Adelman Daniel C Md Chief Medical Officer | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 22,343 | $34.50 | $770,834.00 | (100%) 22.34K to 0 | |
| 14-Oct-20 4:15 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Falberg Kathryn E Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Seltzer Stacey Denenberg Director | Aimmune Therapeutics, Inc. (AIMT) | 13-Oct-20 | Disposition | 7,840 | $34.50 | $270,480.00 | (100%) 7.84K to 0 | |
| 14-Oct-20 4:15 PM View: | Haumann Brett K Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 6,250 | $34.50 | $215,625.00 | (100%) 6.25K to 0 | |
| 14-Oct-20 4:15 PM View: | Sheehy Douglas T. See Remarks | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 47,450 | $34.50 | $1,637,020.00 | (100%) 47.45K to 0 | |
| 14-Oct-20 4:15 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 70,561 | $34.50 | $2,434,350.00 | (43%) 162.26K to 91.7K | |
| 14-Oct-20 4:15 PM View: | Iwicki Mark T Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 39,567 | $34.50 | $1,365,060.00 | (100%) 39.57K to 0 | |
| 14-Oct-20 4:15 PM View: | Adelman Daniel C Md Chief Medical Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 41,464 | $34.50 | $1,430,510.00 | (100%) 41.46K to 0 | |
| 14-Oct-20 4:15 PM View: | McDade Mark Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 26,852 | $34.50 | $926,394.00 | (100%) 26.85K to 0 | |
| 14-Oct-20 4:15 PM View: | Falberg Kathryn E Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 65,192 | $34.50 | $2,249,120.00 | (48%) 135.09K to 69.89K | |
| 14-Oct-20 4:15 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 91,697 | $34.50 | $3,163,550.00 | (100%) 91.7K to 0 | |
| 14-Oct-20 4:15 PM View: | Seltzer Stacey Denenberg Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 10,221 | $34.50 | $352,624.00 | (100%) 10.22K to 0 | |
| 14-Oct-20 4:15 PM View: | Oxtoby Andrew Chief Commercial Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 6,345 | $34.50 | $218,902.00 | (100%) 6.34K to 0 | |
| 14-Oct-20 4:15 PM View: | Falberg Kathryn E Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 69,894 | $34.50 | $2,411,340.00 | (100%) 69.89K to 0 | |
| 14-Oct-20 4:15 PM View: | Bjerkholt Eric Chief Financial Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 27,805 | $34.50 | $959,272.00 | (100%) 27.8K to 0 | |
| 14-Oct-20 4:15 PM View: | Dallas Jayson Donald Alexan... President and CEO Director | Aimmune Therapeutics, Inc. (AIMT) | 10-Oct-20 | Disposition (change in control) | 30,422 | $34.50 | $1,049,560.00 | (100%) 30.42K to 0 | |
| 05-Oct-20 9:14 PM View: | Sheehy Douglas T. See Remarks | Aimmune Therapeutics, Inc. (AIMT) | 05-Oct-20 | Option Exercise | 30,888 | $12.95 | $400,000.00 | 57% 54.54K to 85.43K | |
| 05-Oct-20 9:13 PM View: | Bjerkholt Eric Chief Financial Officer | Aimmune Therapeutics, Inc. (AIMT) | 05-Oct-20 | Option Exercise | 5,200 | $19.44 | $101,088.00 | 12% 44.64K to 49.84K | 4% |
| 05-Oct-20 9:20 PM View: | Adelman Daniel C Md Chief Medical Officer | Aimmune Therapeutics, Inc. (AIMT) | 02-Oct-20 | Option Exercise | 34,932 | $11.45 | $399,971.00 | 121% 28.88K to 63.81K | |
| 23-Sep-20 9:35 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 21-Sep-20 | Acquisition (other) | 91,697 | -- | -- | 1% 6.19M to 6.28M | |
| 23-Sep-20 9:35 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 21-Sep-20 | Disposition (other) | 6,113,130 | -- | -- | (97%) 6.28M to 170.1K | |
| 16-Sep-20 5:19 PM View: | Oxtoby Andrew Chief Commercial Officer | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 840 | $34.25 | $28,770.00 | (3%) 27.43K to 26.59K | |
| 16-Sep-20 5:18 PM View: | Bjerkholt Eric Chief Financial Officer | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 840 | $34.25 | $28,770.00 | (2%) 45.39K to 44.55K | |
| 16-Sep-20 5:20 PM View: | Sheehy Douglas T. See Remarks | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 840 | $34.25 | $28,770.00 | (2%) 55.38K to 54.54K | |
| 16-Sep-20 5:17 PM View: | Adelman Daniel C Md Chief Medical Officer | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 840 | $34.25 | $28,770.00 | (3%) 29.71K to 28.88K | |
| 16-Sep-20 5:17 PM View: | Dallas Jayson Donald Alexan... President and CEO Director | Aimmune Therapeutics, Inc. (AIMT) | 15-Sep-20 | Payment of Exercise | 1,642 | $34.25 | $56,238.50 | (1%) 118.68K to 117.03K | |
| 26-Jun-20 5:06 PM View: | Dallas Jayson Donald Alexan... President and CEO Director | Aimmune Therapeutics, Inc. (AIMT) | 22-Jun-20 | Payment of Exercise | 7,907 | $18.02 | $142,484.00 | (6%) 126.58K to 118.68K | (12%) |
| 29-May-20 7:17 PM View: | Behar Gregory Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 77% 10.19K to 18.03K | |
| 29-May-20 7:17 PM View: | Haumann Brett K Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 13,313 | -- | -- | 213% 6.25K to 19.56K | |
| 29-May-20 7:13 PM View: | McDade Mark Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 29% 26.85K to 34.69K | |
| 29-May-20 7:15 PM View: | Falberg Kathryn E Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 6% 135.09K to 142.93K | |
| 29-May-20 7:12 PM View: | Seltzer Stacey Denenberg Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 77% 10.22K to 18.06K | |
| 29-May-20 7:13 PM View: | Enright Patrick G Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Sale | 7,840 | -- | -- | < 1% 6.18M to 6.19M | |
| 29-May-20 7:17 PM View: | Iwicki Mark T Director | Aimmune Therapeutics, Inc. (AIMT) | 27-May-20 | Grant | 7,840 | -- | -- | 20% 39.57K to 47.41K | |
| 12-May-20 5:23 PM View: | Sheehy Douglas T. See Remarks | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 2,420 | -- | -- | 5% 52.96K to 55.38K | |
| 12-May-20 5:20 PM View: | Oxtoby Andrew Chief Commercial Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 2,420 | -- | -- | 10% 25.02K to 27.43K | |
| 12-May-20 5:25 PM View: | Dallas Jayson Donald Alexan... President and CEO Director | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 3,300 | -- | -- | 3% 123.28K to 126.58K | |
| 12-May-20 5:15 PM View: | Adelman Daniel C Md Chief Medical Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 2,420 | -- | -- | 9% 27.3K to 29.71K | |
| 12-May-20 5:24 PM View: | Bjerkholt Eric Chief Financial Officer | Aimmune Therapeutics, Inc. (AIMT) | 10-May-20 | Grant | 2,420 | -- | -- | 6% 42.97K to 45.39K |
